Skip to main content

News

Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.

News

Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.

AI-Driven Study Redefines Right Heart Health Assessment With Novel Predictive Model

January 4, 2024 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program

GEMINI Study Reveals Diagnostic Advantages for Whole-Genome Sequencing in Hospitalized Infants

December 15, 2023 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

An NCATS-funded study comparing whole genome sequencing to targeted testing in infants suspected of having a genetic disorder could help clinicians better assess the two diagnostic options.

A Tool in Battling COVID-19: Simple Liver Test Developed by VCU Researcher Is Highly Predictive of a Patient’s Need for Respirator

December 12, 2023 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program

N3C Data Validate Two Clinical Tools to Predict COVID-19 Mortality Risk

November 20, 2023 - NCATS News

  • National Clinical Cohort Collaborative (N3C)
  • Our Impact on Big Data

Two new COVID-19 risk-prediction tools tested in part using the NCATS National COVID Cohort Collaborative (N3C) could help clinicians make faster and better treatment decisions.

Newborn Screening for Rare Immune Disorders Led to Earlier Treatment, Improved Survival

November 20, 2023 - NCATS News

  • Rare Diseases Clinical Research Network (RDCRN)

An NCATS-led Rare Diseases Clinical Research Network consortium changed what is known about severe combined immunodeficiency. Researchers developed lifesaving therapies for the disease and pioneered a screening test for newborns.

Scientists Build Ferroptosis Inhibitors to Curb Cell Death Process Linked to Alzheimer’s Disease and Cancer

November 20, 2023 - NCATS News

  • Chemistry Technology

NCATS helped create inhibitors that block a cell death process linked to conditions from cancer to Alzheimer’s disease.

Last updated on July 9, 2026